Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-05-28 00:00:00 ET · period of report 2025-05-23 · accession 0001415889-25-014744 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-05-28 | 2025-05-23+ | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | $1.59 | +86.3K | 116.0K | +290% | +$137.2K |
| DM | 2025-05-28 | 2025-05-23+ | KNSA | Patel Sanj K | COB, CEO, Dir | S - Sale+OE | $27.24 | -86.3K | 96.7K | -47% | -$2.35M |
| DM | 2025-05-28 | 2025-05-23+ | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | $0.00 | -86.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-05-23 | M | A | 4,837 | $1.59 | 101,511 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-05-28 | S | D | 62,116 | $27.33 | 96,674 | D | — | — | (F4) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $27.00 and $27.76. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 3 | Common | Class A Ordinary Share | 2025-05-28 | M | A | 62,116 | $1.59 | 158,790 | D | — | — | |
| 4 | Common | Class A Ordinary Share | 2025-05-23 | S | D | 4,837 | $27.00 | 96,674 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $27.00 and $27.03. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 5 | Common | Class A Ordinary Share | 2025-05-27 | M | A | 19,317 | $1.59 | 115,991 | D | — | — | |
| 6 | Common | Class A Ordinary Share | 2025-05-27 | S | D | 19,317 | $27.01 | 96,674 | D | — | — | (F3) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $27.00 and $27.06. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 7 | Derivative | Share Option | 2025-05-23 | M | D | 4,837 | $0.00 | 81,433 | D | $1.59 · — to 2025-12-15 | 4,837 Class A Ordinary Share | (F5) The option is fully vested and exercisable. |
| 8 | Derivative | Share Option | 2025-05-27 | M | D | 19,317 | $0.00 | 62,116 | D | $1.59 · — to 2025-12-15 | 19,317 Class A Ordinary Share | (F5) The option is fully vested and exercisable. |
| 9 | Derivative | Share Option | 2025-05-28 | M | D | 62,116 | $0.00 | 0 | D | $1.59 · — to 2025-12-15 | 62,116 Class A Ordinary Share | (F5) The option is fully vested and exercisable. |